Christopher P. Prior
Chief Executive Officer presso InterAx Biotech AG
Profilo
Christopher P.
Prior is the founder of BioRexis Pharmaceutical Corp.
(founded in 2002) where he held the position of President & Chief Scientific Officer.
Dr. Prior is also the founder of Principia Pharmaceutical Corp.
Dr. Prior's current jobs include Chief Executive Officer at InterAx Biotech AG (since 2023) and Member at New York Academy of Sciences.
Prior's former jobs include Chief Executive Officer & Director at PhaseBio Pharmaceuticals, Inc. (2008-2014), Chief Executive Officer at Innovate Biopharmaceuticals, Inc., Chief Executive Officer & Director at 9 Meters Biopharma, Inc. (2015-2019), Director-Research & Development at Rhône Poulenc Pharma, Inc., Senior Executive at Human Genome Sciences, Inc., and General Manager at Orchestra Therapeutics, Inc. Dr. Prior holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of London.
Posizioni attive di Christopher P. Prior
Società | Posizione | Inizio |
---|---|---|
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Chief Executive Officer | 24/01/2023 |
Precedenti posizioni note di Christopher P. Prior
Società | Posizione | Fine |
---|---|---|
9 METERS BIOPHARMA, INC. | Chief Executive Officer | 19/02/2019 |
PHASEBIO PHARMACEUTICALS, INC. | Chief Executive Officer | 01/09/2014 |
Innovate Biopharmaceuticals, Inc. /Old/
Innovate Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Innovate Biopharmaceuticals, Inc. manufactures pharmaceutical products. It develops INN-329, a phase III clinical stage solution for magnetic resonance cholangiopancreatography; and Secretin stimulated MRCP, a non-invasive, ionizing, and radiation-free assessment of the pancreaticobiliary system. The company is headquartered in Raleigh, NC. | Chief Executive Officer | - |
Principia Pharmaceutical Corp
Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Principia Pharmaceutical Corp is a derivatives industry analysis company that examines valuation, risk management, and operational requirements for derivatives end users. The private company is based in Norristown, PA. Principia Pharmaceutical was acquired by Human Genome Sciences, Inc., part of GSK Plc from August 03, 2012 on September 11, 2000 for $120 million. The company also provides fixed income and structured credit investor research and whitepaper downloads. The company was founded by Christopher P. Prior. | Founder | - |
Rhône Poulenc Pharma, Inc. | Chief Tech/Sci/R&D Officer | - |
Formazione di Christopher P. Prior
The Trustees of Columbia University in The City of New York | Doctorate Degree |
University of London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
9 METERS BIOPHARMA, INC. | Health Technology |
Aziende private | 8 |
---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
Principia Pharmaceutical Corp
Principia Pharmaceutical Corp Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Principia Pharmaceutical Corp is a derivatives industry analysis company that examines valuation, risk management, and operational requirements for derivatives end users. The private company is based in Norristown, PA. Principia Pharmaceutical was acquired by Human Genome Sciences, Inc., part of GSK Plc from August 03, 2012 on September 11, 2000 for $120 million. The company also provides fixed income and structured credit investor research and whitepaper downloads. The company was founded by Christopher P. Prior. | Health Technology |
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
Rhône Poulenc Pharma, Inc. | |
Innovate Biopharmaceuticals, Inc. /Old/
Innovate Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Innovate Biopharmaceuticals, Inc. manufactures pharmaceutical products. It develops INN-329, a phase III clinical stage solution for magnetic resonance cholangiopancreatography; and Secretin stimulated MRCP, a non-invasive, ionizing, and radiation-free assessment of the pancreaticobiliary system. The company is headquartered in Raleigh, NC. | Health Technology |
InterAx Biotech AG
InterAx Biotech AG Miscellaneous Commercial ServicesCommercial Services InterAx Biotech AG engages in assisting drug candidate design and selection. It focuses on the development of its systems biology platform. The company was founded by Martin Ostermaier, Aurelien Rizk, and Luca Zenone and is headquartered in Villigen, Switzerland. | Commercial Services |
- Borsa valori
- Insiders
- Christopher P. Prior